Skip to content

China National Glioma Registry

China National Glioma Registry

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094600
Enrollment
Unknown
Registered
2024-12-25
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioma

Interventions

Case series:None

Sponsors

Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Patients who underwent surgical treatment at Tiantan Hospital with a pathological diagnosis of glioma, classified according to the 2021 World Health Organization classification of central nervous system tumors. 2.Age between 18 and 75 years, with no gender restrictions. 3.Provided of informed consent, either personally or through a legal representative (such as a spouse, parent, or adult child).

Exclusion criteria

Exclusion criteria: Patients with a pathological diagnosis of other intracranial space-occupying lesions (non-gliomas) or those who are unable to provide informed consent for any reason.

Design outcomes

Primary

MeasureTime frame
Survival Outcomes;Neurological function assessments;Karnofsky Performance Status Score;Language Function Assessment;Cognitive Psychological Assessment;Quality of Life Assessment;

Countries

China

Contacts

Public ContactTao Jiang

Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

taojiang1964@163.com+86 139 1053 1615

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026